Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Southern Cross Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (259)
Cancellation by sponsor (205)
Prescription medicine registration (22)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2026 (2)
2025 (5)
2024 (16)
2023 (30)
2022 (102)
2021 (29)
2020 (50)
2019 (59)
2018 (35)
2017 (50)
2016 (22)
2015 (17)
2014 (9)
2013 (11)
2012 (19)
2011 (9)
2010 (9)
2009 (13)
2008 (3)
2007 (1)
2003 (1)

Search

Sponsor content

492 result(s) found, displaying 311 to 320

ISOTRETINOIN Gx isotretinoin 20mg capsule blister pack (240733)

27 July 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ISOTRETINOIN Gx isotretinoin 20mg capsule blister pack.
AMOXYCLAV DUO SCP 500/125 amoxicillin (as trihydrate) 500mg and clavulanic acid (as potassium clavulanate) 125mg tablet blister pack (231940)

12 July 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMOXYCLAV DUO SCP 500/125 amoxicillin (as trihydrate) 500mg and clavulanic acid (as potassium clavulanate) 125mg tablet blister pack.
AMOXYCLAV DUO FORTE SCP 875/125 amoxicillin (as trihydrate) 875mg and clavulanic acid (as potassium clavulanate) 125mg tablet blister pack (231941)

12 July 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for AMOXYCLAV DUO FORTE SCP 875/125 amoxicillin (as trihydrate) 875mg and clavulanic acid (as potassium clavulanate) 125mg tablet blister pack.
PHARMACOR AMISULPRIDE amisulpride 200 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
PHARMACOR AMISULPRIDE amisulpride 400 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
PHARMACOR AMISULPRIDE amisulpride 100 mg uncoated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
EXEMESTANE AN exemestane 25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
TEMOLIDE temozolomide 5 mg capsule bottle Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
LEFLUNOMIDE AN leflunomide 20mg tablet bottle Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
MOXICLAV DUO 500/125 amoxicillin trihydrate 500mg and clavulanic acid 125mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd

Pages

First page
Previous page
…
Page 28
Page 29
Page 30
Page 31
Current page 32
Page 33
Page 34
Page 35
Page 36
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.